MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-23-2026
Waters Corporation Cash Conversion Cycle 2011-2026 | WAT
Annual Cash Conversion Cycle Waters Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 731 | 724 | 327 | 282 | 333 | 181 | 187 | 168 | 164 | 162 | 167 | 160 | 165 | 167 | 151 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 731 | 151 | 271 |
Quarterly Cash Conversion Cycle Waters Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 334 | 322 | 335 | - | 78.9 | 79.6 | 95.2 | - | 84.9 | 84.8 | 93.7 | - | 38.7 | - | 80.6 | 135 | 170 | 157 | 170 | 133 | 169 | 200 | 223 | 158 | 196 | 189 | 205 | 144 | 174 | 171 | 183 | 140 | 166 | 169 | 180 | 142 | 166 | 164 | 180 | 147 | 170 | 171 | 179 | 139 | 162 | 164 | 179 | 140 | 171 | 173 | 181 | 147 | 169 | 171 | 174 | 135 | 153 | 156 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 335 | 38.7 | 163 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
111 | $ 116.09 | 0.48 % | $ 35.3 B |  USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
142 | $ 127.85 | -0.03 % | $ 20.3 B | USA |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 1.65 | -1.2 % | $ 2.19 M | USA |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 84.13 | -0.24 % | $ 5.68 B | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | $ 25.25 | 3.23 % | $ 701 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 415.77 | 1.2 % | $ 12 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.49 | 0.07 % | $ 20 B |  Niderland |
 |
CareDx, Inc
CDNA
|
51.5 | $ 21.59 | 1.67 % | $ 1.15 B | USA |
 |
Senseonics Holdings
SENS
|
36.1 | $ 7.05 | -0.07 % | $ 294 M | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
Soleno Therapeutics
SLNO
|
-398 | $ 52.73 | 0.01 % | $ 2.68 B | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 16.04 | -1.67 % | $ 485 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 470.4 | 0.18 % | $ 177 B | USA |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.65 | 0.18 % | $ 61.9 M |  Irlanda |
 |
Charles River Laboratories International
CRL
|
65 | $ 172.63 | 1.68 % | $ 8.56 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 60.26 | -1.17 % | $ 3.6 B | USA |
 |
Guardant Health
GH
|
79.6 | $ 90.75 | 2.07 % | $ 11.4 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 2.0 | 1.27 % | $ 8.85 M | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
150 | $ 9.53 | -0.16 % | $ 2.07 B | USA |
 |
Biomerica
BMRA
|
172 | $ 2.16 | 0.93 % | $ 4.96 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 17.26 | 0.15 % | $ 386 M | USA |
 |
ICON Public Limited Company
ICLR
|
62 | $ 101.26 | -0.89 % | $ 8.35 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 264.04 | 0.09 % | $ 22 B | USA |
 |
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 8.49 | 2.35 % | $ 1.09 B | USA |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.77 | -0.21 % | $ 442 M | USA |
 |
Natera
NTRA
|
81.5 | $ 206.37 | 1.29 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 197.48 | 0.62 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |